Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND TERT, EST2, Q8NG46, Q8N6C3, Q2XS35, O14783, O14746, 7015, hEST2, TCS1, TRT, TP2 AND Prognosis
11 results:

  • 1. MCCC2 is a novel mediator between mitochondria and telomere and functions as an oncogene in colorectal cancer.
    Liu W; Chen S; Xie W; Wang Q; Luo Q; Huang M; Gu M; Lan P; Chen D
    Cell Mol Biol Lett; 2023 Oct; 28(1):80. PubMed ID: 37828426
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. The genetic alterations of rectal neuroendocrine tumor and indications for therapy and prognosis: a systematic review.
    Li K; Liu Y; Han J; Gui J; Zhang X
    Endocr J; 2023 Feb; 70(2):197-205. PubMed ID: 36403965
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. RNA Binding Protein-Based Model for Prognostic Prediction of colorectal cancer.
    Li T; Hui W; Halike H; Gao F
    Technol Cancer Res Treat; 2021; 20():15330338211019504. PubMed ID: 34080453
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Telomerase reverse transcriptase promoter mutations in cancers derived from multiple organ sites among middle eastern population.
    Siraj AK; Bu R; Iqbal K; Parvathareddy SK; Siraj N; Siraj S; Diaz MRF; Rala DR; Benito AD; Sabido MA; Al-Rasheed M; Al-Obaisi KAS; Al-Haqawi W; Victoria IG; Al Balawy W; Abedalthagafi M; Wakil SM; Ajarim D; Mohammed S; Alhussain T; Tulbah A; Al-Badawi IA; Al-Dayel F; Al-Kuraya KS
    Genomics; 2020 Mar; 112(2):1746-1753. PubMed ID: 31669704
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Upregulation of mtSSB by interleukin-6 promotes cell growth through mitochondrial biogenesis-mediated telomerase activation in colorectal cancer.
    Wang G; Wang Q; Huang Q; Chen Y; Sun X; He L; Zhan L; Guo X; Yin C; Fang Y; He X; Xing J
    Int J Cancer; 2019 May; 144(10):2516-2528. PubMed ID: 30415472
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Relative telomere lengths in tumor and normal mucosa are related to disease progression and chromosome instability profiles in colorectal cancer.
    Suraweera N; Mouradov D; Li S; Jorissen RN; Hampson D; Ghosh A; Sengupta N; Thaha M; Ahmed S; Kirwan M; Aleva F; Propper D; Feakins RM; Vulliamy T; Elwood NJ; Tian P; Ward RL; Hawkins NJ; Xu ZZ; Molloy PL; Jones IT; Croxford M; Gibbs P; Silver A; Sieber OM
    Oncotarget; 2016 Jun; 7(24):36474-36488. PubMed ID: 27167335
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Clinical Relevance of Telomere Status and Telomerase Activity in colorectal cancer.
    Fernández-Marcelo T; Sánchez-Pernaute A; Pascua I; De Juan C; Head J; Torres-García AJ; Iniesta P
    PLoS One; 2016; 11(2):e0149626. PubMed ID: 26913901
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. The Sensitive Detection of Telomerase Reverse Transcriptase Promoter Mutation by Amplification Refractory Mutation System-PCR.
    Liu J; Zhao Z; Sun M; Chen K; Yuan W; Jiang G
    Genet Test Mol Biomarkers; 2016 Feb; 20(2):90-3. PubMed ID: 26741813
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. High levels of SIRT1 expression enhance tumorigenesis and associate with a poor prognosis of colorectal carcinoma patients.
    Chen X; Sun K; Jiao S; Cai N; Zhao X; Zou H; Xie Y; Wang Z; Zhong M; Wei L
    Sci Rep; 2014 Dec; 4():7481. PubMed ID: 25500546
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Telomerase activity of blood samples and recurrence of colorectal cancer.
    Ohnishi T; Watanabe T; Nozawa H; Kitayama J; Nagawa H
    Hepatogastroenterology; 2008; 55(86-87):1513-8. PubMed ID: 19102333
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Telomerase subunit immunoreactivity and recurrence in colorectal cancer.
    Ohnishi T; Watanabe T; Nozawa H; Nagawa H
    Hepatogastroenterology; 2006; 53(68):188-91. PubMed ID: 16608021
    [TBL] [Abstract] [Full Text] [Related]  

    of 1.